The role of pharmacokinetics in the clinical treatment of metastases.
Pannuti
F
F
Division of Oncology, M. Malpighi Hospital, Bologna, Italy.
Camaggi
C M
CM
Strocchi
E
E
D000970:Antineoplastic Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004317:Doxorubicin / Q000493:pharmacokinetics; D015251:Epirubicin / Q000493:pharmacokinetics; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D017258:Medroxyprogesterone Acetate; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology*; D013629:Tamoxifen / Q000493:pharmacokinetics
D000970:Antineoplastic Agents; D013629:Tamoxifen; D015251:Epirubicin; D004317:Doxorubicin; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone